Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dental Distributor Enters Rehab With AbilityOne, Boosts Territorial Sales Reps

This article was originally published in The Gray Sheet

Executive Summary

Patterson Dental will retain AbilityOne's management team and physical therapy sales force upon closing a $575 mil. purchase of the privately held rehab business by Oct. 25

You may also be interested in...



German Dental Firm Sirona Buys Schick To Integrate Imaging Systems

Sirona Dental Systems' $1.46 bil. purchase of Schick Technologies will allow the firms to combine their imaging technologies into integrated units

German Dental Firm Sirona Buys Schick To Integrate Imaging Systems

Sirona Dental Systems' $1.46 bil. purchase of Schick Technologies will allow the firms to combine their imaging technologies into integrated units

Financings In Brief

WorldHeart relisting: Stock (WHTOF) resumes trading on Nasdaq at $9.50 following seven-to-one consolidation approved by shareholders Nov. 25, 16 months after being delisted. On Sept. 23, the company issued $63.5 mil. in common stock and converted $58 mil. of preferred shares into roughly 5 mil. common shares. Shareholders also agreed to convert the remaining $20 mil. in preferred shares and $3.5 mil. in accrued dividends. Following the restructuring and consolidation, the Ottawa firm has no preferred shares outstanding, about 15 mil. common shares and no debt. WorldHeart recently announced a new strategy for the U.S. marketing of its Novacor left-ventricular assist device, taking advantage of Medicare reimbursement for investigational LVADs (1"The Gray Sheet" Nov. 10, 2003, p. 39)...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT018898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel